On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
Late last month, it was announced that the Intrabeam radiotherapy technology that delivers a single shot dose of radiation to women with early breast cancer will be available in the public health system in Australia from July 2015. So, will New Zealand follow suit?
Read all the latest news from BCAC member group, The Gift of Knowledge in their most recent newsletter for December 2014. Click here http://www.giftofknowledge.co.nz/Newsletters/December-2014/#toc
Breast cancer patients in Wellington who receive Herceptin will soon be treated in a dedicated chemotherapy unit which aims to give them a faster service, easier access and a better overall experience.
BCAC will meet the new Minister of Health, Jonathan Coleman, in March 2015 to highlight issues and concerns in the breast cancer community and we need your input to help identify the key priorities.
This is your opportunity to have your voice heard so if you are aware of any issues or problems with the treatment and support of New Zealanders with breast cancer, please let us know so we can inform the Minister and offer workable solutions.
Following a successful campaign last year, Storage King throughout New Zealand is again supporting the Breast Cancer Aotearoa Coalition (BCAC) this October.
In 2013 Storage King in New Zealand teamed up with BCAC and raised more than $3000 for the charity organisation and this year stores across the country are aiming to do their bit once again.
Beyond the pink ribbons, the TV advertisements encouraging early detection and the fundraising events to raise money for breast cancer are those, both women and men, who are living with metastatic breast cancer – advanced cancer which has spread through the body.
Medical professionals have labelled the latest results from a clinical study showing breast cancer drug Perjeta greatly extends lives as "extraordinary" and an "unprecedented success."
A recent Australian court ruling allowing US biotech company Myriad Genetics to continue to own the patent over the BRCA1 gene is not expected to have a significant impact on patients or research here in New Zealand, according to local experts.
The Australian breast cancer patient Yvonne D’Arcy, whom launched the original case in 2010 against Myriad Genetics, did so over fears of the potential rise in costs to cancer patients if genes are patented.
Sweet Louise currently has 444 members, and since their launch in 2006, they have supported more than 1400 men and women with metastatic breast cancer. One of the key areas of focus this year has been family support.
Following a survey earlier this year, the Auckland bi-monthly Men's Group now have a speaker at each meeting, and this is appealing to more men supporting their family members with life threatening illness.
A new study has revealed the benefits of mammograms for women aged 75 years and older.
The research, published in the journal Radiology, shows that mammogram-detected breast cancers are found at an earlier stage; require less treatment; and lead to better survival rates.